Advanced Drug Delivery Reviews logo Elsevier logo

Publisher: Elsevier

Volume 54, Number 10, 18 November 2002
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Editorial Board
pp. ii-ii(1)

Pharmacogenetics of CYP enzymes and drug transporters: remarkable recent advances
pp. 1241-1242(2)

Pharmacogenetics: Is the right drug for the right patient sufficient?
pp. 1243-1244(2)
Authors: Brouwer K.L.R.; Pollack G.M.

CYP2A6 genetic variation and potential consequences
pp. 1245-1256(12)
Authors: Xu C.; Goodz S.; Sellers E.M.; Tyndale R.F.

CYP2C9 allelic variants: ethnic distribution and functional significance
pp. 1257-1270(14)
Authors: Xie H.-G.; Prasad H.C.; Kim R.B.; Stein C.M.

Genetic contribution to variable human CYP3A-mediated metabolism
pp. 1271-1294(24)
Authors: Lamba J.K.; Lin Y.S.; Schuetz E.G.; Thummel K.E.

The influence of MDR1 polymorphisms on P-glycoprotein expression and function in humans
pp. 1295-1310(16)
Author: Fromm M.F.

Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): its impact on drug disposition
pp. 1311-1331(21)
Authors: Suzuki H.; Sugiyama Y.

Therapeutic and biological importance of getting nucleotides out of cells: a case for the ABC transporters, MRP4 and 5
pp. 1333-1342(10)
Authors: Adachi M.; Reid G.; Schuetz J.D.

Pharmacogenomics of organic anion-transporting polypeptides (OATP)
pp. 1343-1352(10)
Authors: Tirona R.G.; Kim R.B.

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A